Author of the publication

Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.

, , , and . Journal of Immunology, 160 (11): 5596--5604 (June 1998)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting., , , , , and . Proceedings of the National Academy of Sciences of the United States of America, 96 (2): 628--633 (January 1999)Multiple forms of complement C3 in trout that differ in binding to complement activators., , , and . Proceedings of the National Academy of Sciences of the United States of America, 93 (16): 8546--8551 (August 1996)Structure and biology of complement protein C3, a connecting link between innate and acquired immunity., and . Immunological reviews, (April 2001)Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation., , , , , , and . Blood, 92 (5): 1661--1667 (September 1998)Solution structure of Compstatin, a potent complement inhibitor., , , and . Protein science : a publication of the Protein Society, 7 (3): 619--627 (March 1998)Cloning and purification of the rainbow trout fifth component of complement (C5)., , , , , , , and . Developmental and comparative immunology, 25 (5-6): 419--430 (May 2001)Mechanism of complement inactivation by glycoprotein C of herpes simplex virus., , , , , and . Journal of Immunology, 158 (4): 1763--1771 (February 1997)Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics., and . Immunopharmacology, 49 (1-2): 133--148 (August 2000)Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts., , , , , , , , , and . Xenotransplantation, 6 (1): 52--65 (February 1999)Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin., , , , , and . Journal of Immunology, 165 (5): 2491--2499 (September 2000)